Abstract:Objectives: To analyze Heart Team decisions and outcomes following failure of surgical aortic valve replacement (SAVR) prostheses. Methods: Patients undergoing re-operations following index SAVR (Redo-SAVR) and those undergoing valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) following SAVR were included in this study. Patients who underwent index SAVR and/or Redo-SAVR for endocarditis were excluded. Data are presented as medians and 25th-75th percentiles, or absolute numbers and percentages. Outcomes were analyzed in accordance to the VARC-3 criteria. Results: Between 01/2015 and 03/2021, 53 patients underwent Redo-SAVR, 103 patients ViV-TAVR. Mean EuroSCORE II was 5.7% (3.5-8.5) in the Redo-SAVR group and 9.2% (5.4-13.6) in the ViV group. In the Redo-SAVR group, 12 patients received aortic root enlargement (22.6%). Length of hospital and ICU stay was longer in the Redo-SAVR group (p < 0.001; p < 0.001), PGmax and PGmean were lower in the Redo-SAVR group as compared to the ViV-TAVR group (18 mmHg (10-30) vs. 26 mmHg (19-38), p < 0.001) (9 mmHg (6-15) vs. 15 mmHg (9-21), p < 0.001). A higher rate of paravalvular leakage was seen in the ViV-TAVR group (p = 0.013). VARC-3 Early Safety were comparable between the two populations (p = 0.343). Survival at 1 year and 5 years was 82% and 36% in the ViV-TAVR cohort and 84% and 77% in the Redo-SAVR cohort. The variables were patient age (OR 1.061; [95% CI 1.020-1.104], p = 0.004), coronary heart disease (OR 2.648; [95% CI 1.160-6.048], p = 0.021), and chronic renal insufficiency (OR 2.711; [95% CI 1.160-6.048], p = 0.021) showed a significant correlation to ViV-TAVR. Conclusions: Heart Team decisions are crucial in the treatment of patients with degenerated aortic bioprostheses and lead to a low mortality in both treatment paths thanks to patient-specific therapy planning. ViV-TAVR offers a treatment for elderly or intermediate-risk profile patients with comparable short-term mortality. However, this therapy is associated with increased pressure gradients and a high prevalence of paravalvular leakage. Redo-SAVR enables the surgical treatment of concomitant cardiac pathologies and allows anticipation for later VIV-TAVR by implanting the largest possible valve prostheses.

[Studies on the assimilation of inorganic selenium by yeast].

Evolvable Systems: From Biology to Hardware, 7th International Conference, ICES 2007, Wuhan, China, September 21-23, 2007, Proceedings

Aortic Root Reconstruction in Acute Type A Aortic Dissection: Comparison of Valve-Sparing Aortic Root Reimplantation Versus Composite Replacement

Long-term Outcomes Following Valve-Sparing Root Replacement with Concomitant Mitral Repair

Modified bio-Bentall procedure: 10-year experience

Long-term outcomes after aortic root replacement for bicuspid aortic valve–associated aneurysm

Effect of dose, route, and schedule of BCG on antibody titer and survival of murine skin grafts across a weak histocompatibility barrier

Short-term follow-up of valve-sparing aortic root replacement

[Surgery for type A aortic dissection: long-term results and risk factor analysis]

Long-term Results of Valve-Sparing Aortic Root Replacement in Acute Type A Aortic Dissection

Reintervention after valve-sparing aortic root replacement: A comprehensive analysis of 781 David V procedures

Concomitant Annular Enlargement in Minimally Invasive Aortic Valve Replacement

Early and midterm results of valve-sparing aortic root reconstruction with a bovine pericardium patch for patients with acute type a aortic dissection

[Minimally Invasive Aortic Valve Replacement for Isolated Aortic Valve Disease: Clinical Analysis of 101 Consecutive Patients].

Syntheses and structures of M(L)(X)BPh4 complexes {M=Co(II), Zn(II); L=cis-1,3,5-tris[3-(2-furyl)prop-2-enylideneamino]cyclohexane, X=OAc, NO3}: structural models of the active site of carbonic anhydrase

Sixteen-year results of composite aortic root replacement for non-dissecting chronic aortic aneurysms

Long-term outcomes and predictors of recurrent aortic regurgitation after aortic valve-sparing and reconstructive cusp surgery: a single centre experience

Selective Sinus Replacement for Aortic Root Aneurysm: Durable Approach in Selected Patients

Tailoring the porous hierarchy and the tetrahedral aluminum content by using carboxylate ligands: hierarchically structured macro-mesoporous aluminosilicates from a single molecular source.

Failure of Surgical Aortic Valve Prostheses: An Analysis of Heart Team Decisions and Postoperative Outcomes

Late reoperations after acute aortic dissection repair: Single-center experience